Literature DB >> 8211491

Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa.

B D Schoub1, N K Blackburn, S Johnson, J M McAnerney.   

Abstract

A study of human parvovirus B19 infection in 1,967 pregnant women of all races in Johannesburg revealed an overall prevalence of 24.9% for IgG antibodies and 3.3% for IgM antibodies. Of the 64 IgM-positive sera indicating active infection, 62 were resistant to urea denaturation. No differences in the prevalence of IgG antibodies between population groups were observed, but active infections, as demonstrated by IgM antibodies, were significantly more prevalent in black than in white, coloured or Asian mothers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8211491

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  Identification and characterization of persistent human erythrovirus infection in blood donor samples.

Authors:  Daniel Candotti; Nermin Etiz; Armen Parsyan; Jean-Pierre Allain
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19.

Authors:  Nele Goeyvaerts; Niel Hens; Marc Aerts; Philippe Beutels
Journal:  Biostatistics       Date:  2010-09-14       Impact factor: 5.899

3.  The magnitude and correlates of Parvovirus B19 infection among pregnant women attending antenatal clinics in Mwanza, Tanzania.

Authors:  Mariam M Mirambo; Fatma Maliki; Mtebe Majigo; Martha F Mushi; Nyambura Moremi; Jeremiah Seni; Dismas Matovelo; Stephen E Mshana
Journal:  BMC Pregnancy Childbirth       Date:  2017-06-07       Impact factor: 3.007

4.  Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: A cross-sectional survey.

Authors:  Lola Madrid; Rosauro Varo; Sonia Maculuve; Tacilta Nhampossa; Carmen Muñoz-Almagro; Enrique J Calderón; Cristina Esteva; Carla Carrilho; Mamudo Ismail; Begoña Vieites; Vicente Friaza; María Del Carmen Lozano-Dominguez; Clara Menéndez; Quique Bassat
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

5.  Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.

Authors:  Helen M Faddy; Elise C Gorman; Veronica C Hoad; Francesca D Frentiu; Sarah Tozer; R L P Flower
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

6.  Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling.

Authors:  Stéphanie Blaizot; Sereina A Herzog; Steven Abrams; Heidi Theeten; Amber Litzroth; Niel Hens
Journal:  BMC Med Res Methodol       Date:  2019-03-07       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.